Christopher Lamie, Daniel Bader, Kathryn Graziano, Radley Horton, Kecil John, Natalie O'Hern, Sophia Spungin, Amanda Stevens
Many fundamental aspects of New York State's climate have already begun to change, and the changes are projected to continue—and in some cases, accelerate—throughout the 21st century. This chapter explores observed and projected changes in a variety of physical variables that relate directly to weather and climate, starting with average and extreme air temperature and proceeding to the associated effects on precipitation, extreme events, and core properties of New York's coastal and inland waters. These climate attributes and hazards lead to impacts throughout the eight sectors of this assessment.
{"title":"New York State Climate Impacts Assessment Chapter 02: New York State's Changing Climate","authors":"Christopher Lamie, Daniel Bader, Kathryn Graziano, Radley Horton, Kecil John, Natalie O'Hern, Sophia Spungin, Amanda Stevens","doi":"10.1111/nyas.15240","DOIUrl":"https://doi.org/10.1111/nyas.15240","url":null,"abstract":"Many fundamental aspects of New York State's climate have already begun to change, and the changes are projected to continue—and in some cases, accelerate—throughout the 21st century. This chapter explores observed and projected changes in a variety of physical variables that relate directly to weather and climate, starting with average and extreme air temperature and proceeding to the associated effects on precipitation, extreme events, and core properties of New York's coastal and inland waters. These climate attributes and hazards lead to impacts throughout the eight sectors of this assessment.","PeriodicalId":8250,"journal":{"name":"Annals of the New York Academy of Sciences","volume":"12 1","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142793328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicholas B. Rajkovich, Carrie Brown, Illya Azaroff, Erik Backus, Shannon Clarke, Jared Enriquez, Bethany Greenaway, Meghan T. Holtan, Jamal Lewis, Ozgem Ornektekin, Laurie Schoeman, Amanda Stevens
New York State has nearly 5.3 million buildings, and all of them are vulnerable in some way to the impacts of climate change. Understanding these impacts is critical, because risks to buildings not only threaten individual lives but also pose threats to community-level resilience. This chapter examines the impacts of climate change on buildings and, by extension, the people and communities they shelter and support. It also highlights building types and populations that are at particular risk and presents adaptation strategies to protect the state's existing and future building stock from climate impacts.
{"title":"New York State Climate Impacts Assessment Chapter 04: Buildings","authors":"Nicholas B. Rajkovich, Carrie Brown, Illya Azaroff, Erik Backus, Shannon Clarke, Jared Enriquez, Bethany Greenaway, Meghan T. Holtan, Jamal Lewis, Ozgem Ornektekin, Laurie Schoeman, Amanda Stevens","doi":"10.1111/nyas.15200","DOIUrl":"https://doi.org/10.1111/nyas.15200","url":null,"abstract":"New York State has nearly 5.3 million buildings, and all of them are vulnerable in some way to the impacts of climate change. Understanding these impacts is critical, because risks to buildings not only threaten individual lives but also pose threats to community-level resilience. This chapter examines the impacts of climate change on buildings and, by extension, the people and communities they shelter and support. It also highlights building types and populations that are at particular risk and presents adaptation strategies to protect the state's existing and future building stock from climate impacts.","PeriodicalId":8250,"journal":{"name":"Annals of the New York Academy of Sciences","volume":"15 1","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142793331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Deep Dutta, A. B. M. Kamrul-Hasan, Vineet Surana, Rajiv Singla, Deepak Khandelwal, Sameer Aggarwal, Lakshmi Nagendra, Saptarshi Bhattacharya
The glucagon receptor antagonist (GRA) volagidemab is the first-in-class fully human monoclonal antibody that inhibits glucagon receptor. GRA can improve glycemia by reducing endogenous glucose production and reduce risks of diabetic ketoacidosis by suppressing ketogenesis. This systematic review and meta-analysis analyzed the efficacy and safety of volagidemab in type-1 diabetes (T1D). Electronic databases were searched for randomized controlled trials (RCTs) involving T1D patients receiving volagidemab. The primary outcome was to evaluate changes in total daily dose (TDD) of insulin. The secondary outcomes were to evaluate changes in measures of glycemia, hypoglycemia, and adverse events. Data from 3 RCTs (98 patients) were analyzed. Volagidemab (70 mg/week) was associated with a significant reduction in TDD of insulin requirement (mean difference [MD]: −8.45 units/day (95% confidence interval [CI]: [−12.09, −4.81]); I2 = 83%; p < 0.01) and average blood glucose (MD: −21.42 mg/dL (95% CI: [−37.10, −5.74]); I2 = 88%; p < 0.01), compared to placebo. Volagidemab use was associated with a significant increase in time in range (blood glucose: 70–180 mg/dL) (MD: 10.93% (95% CI: [6.69, 15.17]); I2 = 55%; p < 0.01) and significant reduction in time above range (blood glucose >180 mg/dL) (MD: −11.93% (95% CI: [−14.71, −9.15]); I2 = 6%; p < 0.01) without any impact on time below range (blood glucose <70 mg/dL) (MD: 0.14% (95% CI: [−0.56, 0.84]); I2 = 0%; p = 0.70), compared to placebo. Occurrence of treatment-emergent adverse events (odds ratio [OR]: 0.96 (95% CI: [0.36, 2.56]); I2 = 8%; p = 0.94) and hypoglycemia (OR: 0.56 (95% CI: [0.11, 2.89]); I2 = 0%; p = 0.49) were similar among volagidemab users as compared to placebo. Short-term volagidemab use was associated with significant reduction in insulin requirement along with improvement in glycemia.
{"title":"Efficacy and safety of the glucagon receptor antagonist volagidemab in type-1 diabetes: A systematic review and meta-analysis","authors":"Deep Dutta, A. B. M. Kamrul-Hasan, Vineet Surana, Rajiv Singla, Deepak Khandelwal, Sameer Aggarwal, Lakshmi Nagendra, Saptarshi Bhattacharya","doi":"10.1111/nyas.15262","DOIUrl":"https://doi.org/10.1111/nyas.15262","url":null,"abstract":"The glucagon receptor antagonist (GRA) volagidemab is the first-in-class fully human monoclonal antibody that inhibits glucagon receptor. GRA can improve glycemia by reducing endogenous glucose production and reduce risks of diabetic ketoacidosis by suppressing ketogenesis. This systematic review and meta-analysis analyzed the efficacy and safety of volagidemab in type-1 diabetes (T1D). Electronic databases were searched for randomized controlled trials (RCTs) involving T1D patients receiving volagidemab. The primary outcome was to evaluate changes in total daily dose (TDD) of insulin. The secondary outcomes were to evaluate changes in measures of glycemia, hypoglycemia, and adverse events. Data from 3 RCTs (98 patients) were analyzed. Volagidemab (70 mg/week) was associated with a significant reduction in TDD of insulin requirement (mean difference [MD]: −8.45 units/day (95% confidence interval [CI]: [−12.09, −4.81]); <i>I</i><sup>2</sup> = 83%; <i>p</i> < 0.01) and average blood glucose (MD: −21.42 mg/dL (95% CI: [−37.10, −5.74]); <i>I</i><sup>2</sup> = 88%; <i>p</i> < 0.01), compared to placebo. Volagidemab use was associated with a significant increase in time in range (blood glucose: 70–180 mg/dL) (MD: 10.93% (95% CI: [6.69, 15.17]); <i>I</i><sup>2</sup> = 55%; <i>p </i>< 0.01) and significant reduction in time above range (blood glucose >180 mg/dL) (MD: −11.93% (95% CI: [−14.71, −9.15]); <i>I</i><sup>2</sup> = 6%; <i>p</i> < 0.01) without any impact on time below range (blood glucose <70 mg/dL) (MD: 0.14% (95% CI: [−0.56, 0.84]); <i>I</i><sup>2</sup> = 0%; <i>p</i> = 0.70), compared to placebo. Occurrence of treatment-emergent adverse events (odds ratio [OR]: 0.96 (95% CI: [0.36, 2.56]); <i>I</i><sup>2</sup> = 8%; <i>p</i> = 0.94) and hypoglycemia (OR: 0.56 (95% CI: [0.11, 2.89]); <i>I</i><sup>2</sup> = 0%; <i>p </i>= 0.49) were similar among volagidemab users as compared to placebo. Short-term volagidemab use was associated with significant reduction in insulin requirement along with improvement in glycemia.","PeriodicalId":8250,"journal":{"name":"Annals of the New York Academy of Sciences","volume":"19 1","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142760766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Evidence shows that gorgonians are more resistant to ocean acidification and rising temperatures than hard corals and are vital to reef health and the reestablishment of disrupted coral reef communities. Gorgonian coral's resilience and its diversity of morphology and environment make it well-suited as a model organism for bioinspired design applied to particle capture. We focus on flow near the polyps, using an updated form of the immersed boundary method to model the fluid–structure interaction of the flexible polyps and the surrounding ocean water. The inlet velocity and the polyp elasticity are simultaneously varied to gain insight into (1) how these parameters affect the emergent reconfiguration of their tentacles and (2) how the interaction of the reconfiguration and inlet velocity impacts passive particle capture. Two main behaviors are observed: a recirculation regime, in which particles recirculate in a region near the oral disk, and a unidirectional regime, in which the particles move unidirectionally through the tentacles without recirculation. Our results show that different regimes support different feeding strategies. We apply these results as bioinspired filtration, discussing how an elastic material could benefit specific engineering applications.
{"title":"Interplay of elasticity and flow velocity on gorgonian feeding and implications for bioinspired design","authors":"Matea Santiago, Laura A. Miller","doi":"10.1111/nyas.15250","DOIUrl":"https://doi.org/10.1111/nyas.15250","url":null,"abstract":"Evidence shows that gorgonians are more resistant to ocean acidification and rising temperatures than hard corals and are vital to reef health and the reestablishment of disrupted coral reef communities. Gorgonian coral's resilience and its diversity of morphology and environment make it well-suited as a model organism for bioinspired design applied to particle capture. We focus on flow near the polyps, using an updated form of the immersed boundary method to model the fluid–structure interaction of the flexible polyps and the surrounding ocean water. The inlet velocity and the polyp elasticity are simultaneously varied to gain insight into (1) how these parameters affect the emergent reconfiguration of their tentacles and (2) how the interaction of the reconfiguration and inlet velocity impacts passive particle capture. Two main behaviors are observed: a recirculation regime, in which particles recirculate in a region near the oral disk, and a unidirectional regime, in which the particles move unidirectionally through the tentacles without recirculation. Our results show that different regimes support different feeding strategies. We apply these results as bioinspired filtration, discussing how an elastic material could benefit specific engineering applications.","PeriodicalId":8250,"journal":{"name":"Annals of the New York Academy of Sciences","volume":"1 1","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142760774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Swingedouw, D., Bily, A., Esquerdo, C., Borchert, L. F., Sgubin, G., Mignot, J., & Menary, M. (2021). On the risk of abrupt changes in the North Atlantic subpolar gyre in CMIP6 models. Annals of the New York Academy of Sciences, 1504(1), 187–201.